Products

What will AGI do for Acetohydroxamic acid?

This classification denotes a chelating agent with the molecular formula C2H5NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4RZ82L2GY5, chemically known as hydroxylamine, n-acetyl- but generally known as acetohydroxamic acid, which bears US NIH Compound Identifier 1990. European Medicines Agency schedules Acetohydroxamic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05224MIG. The term ACETOHYDROXAMIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules acetohydroxamic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule acetohydroxamic acid under HS 29280090 and SITC 51486. As of Q4 2014, ACETOHYDROXAMIC ACID remains the US FDA Preferred Term for this commodity. Acetohydroxamic acid bears US NLM identifiers UMLS ID C0050451 and NCI Concept Code C47381. SMILES: CC(=O)NO.

How AGI delivers it

Four ways AGI delivers for Acetohydroxamic acid

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Acetohydroxamic acid, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Acetohydroxamic acid, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Acetohydroxamic acid connects

measured by

  • Assay Puritymodel
  • Heavy Metals Contentmodel
  • Loss on Dryingmodel
  • Moisture Contentmodel
  • Residual Solventsmodel